Ep 227 - How an artful pivot and IPO is positioning Anteris Technologies to take on the red hot TAVR space

Om avsnittet

In this episode of the DeviceTalks Weekly Podcast, MassDevice Editor Chris Newmarker sits down with Wayne Paterson, CEO of Anteris Technologies, a unique start-up that’s approaching the complicated and competitive TAVR market. Chris Newsmaker and Host Tom Salemi also discuss this week’s Newmarker’s Newsmakers including Medtronic, Boston Scientific, Johnson & Johnson MedTech, NeuroPace and the FDA. This episode was sponsored by DeviceTalks Minnesota. Register to attend the June 11 event at Minnesota.DeviceTalks.com. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 227 - How an artful pivot and IPO is positioning Anteris Technologies to take on the red hot TAVR space

Om avsnittet

Fler avsnitt

Ep 304 - J&J MedTech's Polyphonic Lead Explains Why Surgical Intelligence Is the Next Big Shift in the OR

Ep 303 - Xeltis CEO Schutte on Building a Business Around Tech that Helps the Body Build New Blood Vessels

Ep 302 - Inner Logic CEO Porras explains how autonomous surgery can save us from looming surgeon shortage

Ep 301 - Medtronic’s Grubb on Bringing a Structuralist Perspective to a Growing Structural Heart Portfolio

Ep 300 - How Mobia Medical’s Stroke Recovery Mission Muscled It Past MedTech’s Public Market Malaise

Ep 299 - Surgical Robotics Recap: Steve Bell on SRS, Karl Storz’s Gaudet and Sovato CEO Brian Miller

Ep 298 - Is Fractyl poised to create a new MedTech market by helping former GLP-1 users keep weight off?

Ep 297 - J&J MedTech’s Devi Govender wants to change the lives – and the language – of heart recovery patients

Ep 296 - XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution

Ep 295 - Can Calyxo CEO Catanese Lead New Company Down Familiar Tract to Build Another Urology Powerhouse